Great Point Partners’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
DGM
Great Point Partners's GMAB Position: Q3 2026 in Review
Great Point Partners opened a new position in Genmab (GMAB) in Q3 2026: 525,000 shares worth $18.7M. The stake represents 4.48% of the portfolio and ranks #8 among its holdings.
333 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- Great Point Partners held 525,000 shares of Genmab worth $18.7M as of Q3 2026.
- Genmab was a new Great Point Partners position in Q3 2026.
- Genmab made up 4.48% of Great Point Partners's portfolio in Q3 2026, its #8 holding.
- 333 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on Great Point Partners's 13F filing for Q3 2026, filed 16 Nov 2026.